The researchers at the Helmholtz Center Munich (HMGU) and the TUM have discovered that macrophages from people with mild COVID-19 have an altered inflammatory and metabolic function several months after the infection. Various studies have shown that the amount of leukotrienes has been found to be involved in various antiviral therapies. A further investigation is needed to investigate whether or not a significant amount of coVID-19 infection is linked to developing the virus.
Months after mild COVID-19, increased inflammation persists in immunization cells
